$37.33
0.35% today
Nasdaq, Sep 16, 08:19 pm CET
ISIN
US45166A1025
Symbol
IDYA
Sector
Industry

IDEAYA Biosciences Inc Target price 2024 - Analyst rating & recommendation

IDEAYA Biosciences Inc Classifications & Recommendation:

Buy
100%

IDEAYA Biosciences Inc Price Target

Target Price $57.46
Price $37.46
Potential
Number of Estimates 13
13 Analysts have issued a price target IDEAYA Biosciences Inc 2025 . The average IDEAYA Biosciences Inc target price is $57.46. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 13 Analysts recommend IDEAYA Biosciences Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the IDEAYA Biosciences Inc stock has an average upside potential 2025 of . Most analysts recommend the IDEAYA Biosciences Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 23.39 9.78
54.07% 58.18%
EBITDA Margin -557.59% -2,398.74%
370.17% 330.20%
Net Margin -637.61% -2,021.86%
200.55% 217.10%

13 Analysts have issued a sales forecast IDEAYA Biosciences Inc 2024 . The average IDEAYA Biosciences Inc sales estimate is

$9.8m
Unlock
. This is
18.22% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$25.0m 109.03%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $23.4m 54.07%
2024
$9.8m 58.18%
Unlock
2025
$15.1m 54.40%
Unlock
2026
$75.2m 397.81%
Unlock
2027
$177m 135.34%
Unlock
2028
$550m 210.91%
Unlock

3 Analysts have issued an IDEAYA Biosciences Inc EBITDA forecast 2024. The average IDEAYA Biosciences Inc EBITDA estimate is

$-235m
Unlock
. This is
25.33% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-223m 19.31%
Unlock
, the lowest is
$-254m 35.77%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-130m 115.93%
2024
$-235m 79.90%
Unlock
2025
$-266m 13.58%
Unlock
2026
$-245m 8.21%
Unlock

EBITDA Margin

2023 -557.59% 370.17%
2024
-2,398.74% 330.20%
Unlock
2025
-1,764.64% 26.43%
Unlock
2026
-325.38% 81.56%
Unlock

4 IDEAYA Biosciences Inc Analysts have issued a net profit forecast 2024. The average IDEAYA Biosciences Inc net profit estimate is

$-198m
Unlock
. This is
19.22% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-169m 1.66%
Unlock
, the lowest is
$-214m 28.90%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-149m 38.03%
2024
$-198m 32.60%
Unlock
2025
$-243m 22.90%
Unlock
2026
$-252m 3.63%
Unlock
2027
$-193m 23.41%
Unlock
2028
$-24.4m 87.38%
Unlock

Net Margin

2023 -637.61% 200.55%
2024
-2,021.86% 217.10%
Unlock
2025
-1,609.31% 20.40%
Unlock
2026
-335.01% 79.18%
Unlock
2027
-109.02% 67.46%
Unlock
2028
-4.43% 95.94%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -1.96 -2.60
38.03% 32.65%
P/E negative
EV/Sales 252.00

4 Analysts have issued a IDEAYA Biosciences Inc forecast for earnings per share. The average IDEAYA Biosciences Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-2.60
Unlock
. This is
19.27% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-2.22 1.83%
Unlock
, the lowest is
$-2.81 28.90%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.96 38.03%
2024
$-2.60 32.65%
Unlock
2025
$-3.19 22.69%
Unlock
2026
$-3.31 3.76%
Unlock
2027
$-2.54 23.26%
Unlock
2028
$-0.32 87.40%
Unlock

P/E ratio

Current -17.17 14.11%
2024
-14.41 16.07%
Unlock
2025
-11.73 18.60%
Unlock
2026
-11.32 3.50%
Unlock
2027
-14.78 30.57%
Unlock
2028
-117.06 692.02%
Unlock

Based on analysts' sales estimates for 2024, the IDEAYA Biosciences Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

252.00
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
323.55
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 206.09 730.00%
2024
252.00 22.28%
Unlock
2025
163.22 35.23%
Unlock
2026
32.79 79.91%
Unlock
2027
13.93 57.51%
Unlock
2028
4.48 67.84%
Unlock

P/S ratio

Current 264.61 641.02%
2024
323.55 22.27%
Unlock
2025
209.56 35.23%
Unlock
2026
42.10 79.91%
Unlock
2027
17.89 57.51%
Unlock
2028
5.75 67.84%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today